DEVA FINANCIAL STATEMENTS

Deva Holding A.S. — balance sheet, income statement and cash flow trends

DEVADeva Holding A.S.

🇹🇷 Turkey · IS · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue21 B ₺+7.7%

Gross Profit6.8 B ₺-9.4%

Operating Income763.2 M ₺-72.6%

EBITDA2.5 B ₺-40.2%

Net Income-916.3 M ₺-287.4%

Peer Comparison· Drug Manufacturers - Specialty & Generic

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
DEVA	7.7%	32.5%	12.0%	-4.4%
ORGO	11.9%	70.4%	7.3%	-0.1%
SIGA	-22.1%	65.4%	29.3%	21.6%
TLRY	3.8%	27.7%	-156.2%	-158.8%
HLN	-26.7%	61.5%	25.2%	12.6%
EOLS	9.6%	65.5%	-4.6%	-14.4%
Industry median	7.5%	60.6%	18.2%	4.0%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity28.8 B ₺70%
Current Liabilities9.1 B ₺22%
Long-term Liabilities3.3 B ₺8%

Key Figures

YoY change

Total Assets41.3 B ₺+29.5%

Total Liabilities12.4 B ₺+36.4%

Total Equity28.8 B ₺+26.7%

Cash & ST Investments4.4 B ₺+50.8%

Total Debt6.7 B ₺+10.1%

Net Debt2.9 B ₺-31.4%

Peer Comparison· Drug Manufacturers - Specialty & Generic

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
DEVA	2.00	23.1%	0.89	69.9%
ORGO	3.53	18.6%	-0.57	73.3%
SIGA	3.25	0.4%	-5.27	69.1%
TLRY	2.79	20.4%	-0.07	75.1%
HLN	0.92	52.3%	3.50	50.3%
EOLS	2.04	-573.0%	-8.20	-13.0%
Industry median	2.22	46.3%	1.24	45.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow5.4 B ₺+55.1%

Capital Expenditures-2.7 B ₺—

Free Cash Flow4 B ₺-21.6%

Dividends Paid0 ₺—

Peer Comparison· Drug Manufacturers - Specialty & Generic

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
DEVA	25.8%	19.3%	12.8%	-590.3%
ORGO	6.0%	3.3%	2.7%	-10,828.5%
SIGA	29.6%	29.2%	0.4%	136.9%
TLRY	-5.6%	-8.3%	3.8%	3.5%
HLN	12.5%	11.3%	1.2%	99.0%
EOLS	-12.1%	-14.4%	2.3%	84.3%
Industry median	15.2%	11.6%	2.5%	84.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on DEVA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.